Summary
Looking to buy or sell a cannabis business in 2025? This article offers a practical guide to cannabis M&A due diligence amid a wave of consolidation, distressed assets, and evolving regulations-especially in California. Discover key tips for buyers and sellers, explore recent deal structures, and understand how federal rescheduling could reshape the market. If you’re preparing for a merger or acquisition, don’t go it alone-learn how our cannabis M&A accounting experts can help ensure your financials, compliance, and deal terms are airtight.
In 2025, the U.S. cannabis industry, especially in California, is experiencing a pivotal transformation. A wave of market consolidation, plummeting license values, and shrinking margins is forcing many small-to-mid-sized operators to consider mergers or acquisitions, either as a survival strategy or a growth opportunity. For entrepreneurs, investors, and operators, the question is no longer whether M&A is happening, but how to prepare for it.
In this blog article, we explore the current landscape of cannabis M&A and offer essential due diligence tips for both sellers and buyers navigating this evolving market.
2025 Cannabis Industry Landscape: The Age of Consolidation
The cannabis industry has entered the ‘Scale’ phase of the consolidation curve. According to a market analysis by Flowhub, large and well-capitalized players are acquiring smaller, distressed businesses in both mature and emerging markets. Many smaller businesses in California are merging or selling off their licenses due to oversaturation, declining sales, and increasing tax burdens.
Recent data from SFGate shows that inactive or surrendered cannabis licenses in California now outnumber active ones: 10,828 versus 8,514, respectively. MJBizDaily confirms this growing attrition, noting that many operators are choosing to exit the market entirely.
Q1 2025 cannabis retail sales in California fell to a five-year low of $1.088 billion. As margins shrink and consumer demand flattens, even long-standing businesses are struggling to stay afloat. If you are a potential buyer, this downturn presents unique acquisition opportunities, albeit with significant risk.
Recent Cannabis M&A Deals Worth Watching
M&A activity is heating up despite market challenges. In California, San Francisco-based Blum acquired three dispensaries for $9.7 million in 2024. Similarly, Lowell Farms signed management service agreements for two Los Angeles stores, with an option to purchase equity, an increasingly common strategy to skirt around California’s non-transferable license laws.
Outside of California, Planet 13 purchased a Las Vegas dispensary from Exhale Brands for $6.9 million, using a mix of cash and inventory-based financing. Meanwhile, Minnesota-based Vireo Growth merged with four single-state operators in a $397 million all-stock deal, creating a multi-state platform with nearly 50 dispensaries.
The interesting aspect about these deals is that they reflect a broader industry shift: a move toward strategic acquisitions, regional dominance, and creative deal structures in response to regulatory and financial constraints.
Navigating Regulatory and Financial Landmines
One of the most significant hurdles in cannabis M&A, especially in California, is regulatory compliance. As highlighted by legal experts at Harris Sliwoski LLP, licenses in California cannot be transferred. Instead, deals must be structured as equity purchases where the buyer acquires ownership in the licensed entity. Even then, the state requires at least one original owner to remain listed during the ownership transition.
Compounding the complexity is the lack of access to federal bankruptcy protection. This means distressed cannabis businesses in California often resort to state receiverships, where a court-appointed receiver temporarily operates the business while a new owner applies for licensure at the same location.
Financially, the burden of Section 280E of the IRS tax code further complicates things. On the federal level, cannabis businesses must pay taxes on gross profit rather than net income, making profitability difficult to gauge from traditional financial statements. As this article in the Cannabis Industry Journal points out, neglecting rigorous financial vetting can lead to overpayment and post-close liabilities.
Due Diligence Tips for Buyers
If you are a buyer considering the purchase of a cannabis business, you must be vigilant to avoid costly missteps. Here are critical areas to examine:
- Licensing and Compliance: Confirm that all licenses are active, in good standing, and free of disciplinary actions. Ensure the deal structure is aligned with California’s legal framework.
- Financial Statements: Request at least 3 years of audited or verified financials. Pay close attention to tax returns, cash handling, and cost of goods sold, especially under 280E.
- Red Flags: Missing documents, disorganized books, or overly optimistic projections can signal trouble. Be wary of sellers who push for a fast closing without full transparency.
- Inventory and Assets: Conduct physical inspections of inventory, facilities, and security protocols.
- Deal Terms: Explore flexible deal structures like earn-outs, promissory notes, or stock options to mitigate your upfront risk.
- Advisory Team: Work with cannabis-specialized CPAs and attorneys to ensure a clean transaction and post-close stability.
Due Diligence Tips for Sellers
If you are a seller wanting to maximize value, preparing your cannabis business for sale is a priority. Below are the essential steps to ensure you are adequately prepared to get a top-dollar buyer:
- Thorough Documentation: Organize all legal, financial, and operational records in a digital data room. This level of detailing helps build buyer confidence.
- Compliance Readiness: Consider undergoing a third-party audit to validate your business practices and regulatory standing.
- Determine Valuation Expectations: Set realistic asking prices. When license valuations are low, reflect this in your negotiations.
- Transparency: Be upfront about operational issues, debts, or pending litigation. Openness and honesty will prevent delays and build trust.
- Deal Structuring: Understand that a serious buyer may prefer a phased closing or contingent payments. Be open to flexible terms if it means that it helps to get the deal done.
Conclusion: M&A Opportunities Require Sharp Eyes and Steady Hands
With consolidation accelerating across the cannabis sector, both buyers and sellers have much to gain, but only if they navigate the terrain with care. From California’s regulatory constraints to federal tax complications, due diligence is no longer optional; it’s essential.
The 2025 market is favoring prepared, transparent, and strategic operators. Whether you’re planning to acquire a distressed asset or looking to sell your business at a fair price, proper preparation and specialized advisors will make all the difference.
Stay informed. Stay compliant. And most importantly, be smart about the deals you pursue.
Federal Rescheduling and the M&A Outlook
Another key factor influencing M&A dynamics in 2025 is the federal government’s proposed rescheduling of cannabis from Schedule I to Schedule III. While still pending final approval, this shift could dramatically alter tax implications, most notably by reducing or removing the burden of IRC Section 280E, which currently prohibits cannabis businesses from deducting normal business expenses.
If enacted, rescheduling could not only improve profitability across the industry but also make cannabis companies more attractive to mainstream investors. As valuations rebound, we may see a second wave of M&A driven by more institutional capital, fewer distressed sales, and a stronger appetite for vertical integration. Companies that perform early-stage due diligence now may be better positioned to strike favorable deals before prices rise.
Additionally, changes in federal enforcement priorities and increased access to traditional banking services (via the SAFE Banking Act or related reforms) could further normalize cannabis finance. Improved access to loans and credit would expand buyer pools and enable more creative deal structuring, including leveraged buyouts and equity investments that are currently difficult to execute.
Innovative Deal Structures Gaining Popularity
Due to limited access to capital and falling valuations, cannabis M&A in 2025 is marked by creative deal structuring.
Traditional all-cash deals are now rare, with many acquisitions utilizing:
- Earn-Outs: Sellers receive additional payments based on the target’s post-sale performance, helping buyers reduce the upfront risk.
- Convertible Debt: Investors provide loans that can convert into equity, which reduces pressure on cash-strapped acquirers.
- Vendor Financing: Sellers agree to finance part of the transaction, sometimes backed by inventory or future earnings.
- Management Service Agreements (MSAs): These allow operational control of the target while navigating licensing hurdles, often used in California to meet compliance rules.
This kind of flexibility is vital in a volatile market. Buyers can tailor risk exposure to match cash flow, while sellers can remain involved post-close to ensure smooth transitions and hit performance benchmarks tied to earn-outs or residual equity.
Emerging Markets and Intrastate Growth
While California remains the largest cannabis market in the U.S., many investors are looking to newer state markets for growth potential. States like Missouri, Maryland, Connecticut, and New York have seen increased M&A activity as they implement adult-use programs or expand medical markets.
In these regions, operators often aim to consolidate licenses early, establish local brand dominance, or acquire real estate in high-traffic zones. While the regulatory hurdles are different in each state, buyers accustomed to California’s complexity may find other markets more straightforward. However, understanding local laws remains crucial, especially in states with residency requirements or limited license caps.
Furthermore, single-state operators in states like Michigan, Arizona, and Massachusetts are increasingly viewed as acquisition targets by multi-state operators (MSOs) seeking regional scale. The playbook is familiar: build a strong foothold in one state, demonstrate operational excellence, and become an attractive target for a larger brand looking to enter.
Final Thoughts: Positioning for the Future
Cannabis entrepreneurs in California and across the U.S. are entering a new era of strategic realignment. Whether you’re considering selling, acquiring, or merging, the difference between success and a costly mistake boils down to preparation, transparency, and a firm grasp of regulatory and financial fundamentals.
As more states open their markets and federal policy evolves, M&A will likely become the industry norm rather than the exception. Now is the time to invest in compliance audits, financial planning, and consult advisory teams who understand the complexities of cannabis transactions in California and other states.
For sellers, that means making your business due diligence ready. For buyers, that means knowing where to find value and how to structure a deal that captures it.
If you need help with ensuring financial due diligence for your cannabis business in California’s dynamic M&A landscape, our team is here to help. Our clients vouch for our cannabis accounting services.
Contact us today to learn more about how we can help you with the due diligence required for M&A in the cannabis industry.